Verseon Corp (LON:VSN) insider Fodor,Eniko purchased 6,000 shares of the firm’s stock in a transaction on Wednesday, September 21st. The shares were acquired at an average cost of GBX 161 ($2.10) per share, with a total value of £9,660 ($12,609.32).
Shares of Verseon Corp (LON:VSN) opened at 161.00 on Friday. The stock’s market capitalization is GBX 243.73 million. Verseon Corp has a one year low of GBX 148.00 and a one year high of GBX 230.00. The firm’s 50-day moving average price is GBX 161.00 and its 200-day moving average price is GBX 163.10.
About Verseon Corp
Verseon Corporation is a pharmaceutical company. Its platform is capable of modeling interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology.
Receive News & Ratings for Verseon Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verseon Corp and related companies with MarketBeat.com's FREE daily email newsletter.